59.24 -1.36 (-2.24%) | 04-30 16:02 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 281.66 | 1-year : | 290.15 |
Resists | First : | 241.15 | Second : | 248.41 |
Pivot price | 238.03 | |||
Supports | First : | 229.39 | Second : | 190.86 |
MAs | MA(5) : | 233.54 | MA(20) : | 239.57 |
MA(100) : | 239.01 | MA(250) : | 251.44 | |
MACD | MACD : | -2.1 | Signal : | -1.2 |
%K %D | K(14,3) : | 26.5 | D(3) : | 23.3 |
RSI | RSI(14): 43 | |||
52-week | High : | 287.32 | Low : | 229.39 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ BDX ] has closed above bottom band by 31.8%. Bollinger Bands are 70.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.
If tomorrow: | Open lower | Open higher |
High: | 236.44 - 237.38 | 237.38 - 238.19 |
Low: | 230.77 - 231.94 | 231.94 - 232.95 |
Close: | 232.36 - 234.25 | 234.25 - 235.88 |
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
Exchange:
NYSE
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Instruments & Supplies
|
|
Shares Out | 289 (M) |
Shares Float | 288 (M) |
Held by Insiders | 0.3 (%) |
Held by Institutions | 89.3 (%) |
Shares Short | 2,930 (K) |
Shares Short P.Month | 2,090 (K) |
EPS | 4.34 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 87.68 |
Profit Margin | 6.4 % |
Operating Margin | 10.6 % |
Return on Assets (ttm) | 3.1 % |
Return on Equity (ttm) | 5.1 % |
Qtrly Rev. Growth | 2.5 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 67.46 |
EBITDA (p.s.) | 16.99 |
Qtrly Earnings Growth | -43.5 % |
Operating Cash Flow | 3,430 (M) |
Levered Free Cash Flow | 3,790 (M) |
PE Ratio | 53.87 |
PEG Ratio | 2 |
Price to Book value | 2.67 |
Price to Sales | 3.47 |
Price to Cash Flow | 19.73 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |